Abbvie Inc (NYSE: ABBV) is 4.88% higher on its value in year-to-date trading and has touched a low of $130.96 and a high of $182.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABBV stock was last observed hovering at around $161.67 in the last trading session, with the day’s gains setting it 0.87%.
Currently trading at $162.54, the stock is -6.79% and -7.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.78 million and changing 0.54% at the moment leaves the stock 4.56% off its SMA200. ABBV registered 0.59% gain for a year compared to 6-month gain of 9.85%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.62% loss in the last 1 month and extending the period to 3 months gives it a 0.66%, and is -4.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.72% over the week and 1.75% over the month.
Abbvie Inc (ABBV) has around 50000 employees, a market worth around $287.80B and $54.32B in sales. Current P/E ratio is 59.75 and Fwd P/E is 13.36. Profit margin for the company is 8.87%. Distance from 52-week low is 24.11% and -11.13% from its 52-week high. The company has generated returns on investments over the last 12 months (7.61%).
The EPS is expected to grow by 0.32% this year.
Abbvie Inc (ABBV) Top Institutional Holders
The shares outstanding are 1.77B, and float is at 1.77B with Short Float at 0.74%.
Abbvie Inc (ABBV) Insider Activity
The most recent transaction is an insider sale by Donoghoe Nicholas,the company’sEVP, CHIEF BUS/STRAT OFFICER. SEC filings show that Donoghoe Nicholas sold 21,082 shares of the company’s common stock on Mar 20 ’24 at a price of $176.30 per share for a total of $3.72 million. Following the sale, the insider now owns 55903.0 shares.
Abbvie Inc disclosed in a document filed with the SEC on Mar 18 ’24 that Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER) sold a total of 58,949 shares of the company’s common stock. The trade occurred on Mar 18 ’24 and was made at $178.79 per share for $10.54 million. Following the transaction, the insider now directly holds 60941.0 shares of the ABBV stock.
Still, SEC filings show that on Mar 01 ’24, RICHMOND TIMOTHY J. (EVP, CHIEF HR OFFICER) disposed off 75,680 shares at an average price of $177.27 for $13.42 million. The insider now directly holds 13,837 shares of Abbvie Inc (ABBV).
